TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Double Bond Pharmaceutical AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
952
|
897
|
782 |
Financial expenses |
73
|
1,825
|
867 |
Earnings before taxes |
-7,044
|
-9,295
|
-12,933 |
EBITDA |
-6,842
|
-7,341
|
-11,942 |
Total assets |
3,013
|
3,215
|
8,426 |
Current assets |
2,710
|
2,795
|
6,897 |
Current liabilities |
1,650
|
2,134
|
2,729 |
Equity capital |
1,363
|
1,081
|
5,697 |
- share capital |
34
|
33
|
36 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.2%
|
33.6%
|
67.6% |
Turnover per employee |
95
|
90
|
78 |
Profit as a percentage of turnover |
-739.9%
|
-1036.2%
|
-1653.8% |
Return on assets (ROA) |
-231.4%
|
-232.3%
|
-143.2% |
Current ratio |
164.2%
|
131.0%
|
252.7% |
Return on equity (ROE) |
-516.8%
|
-859.9%
|
-227.0% |
Change turnover |
51
|
178
|
465 |
Change turnover % |
6%
|
25%
|
146% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.